Stay informed with the latest updates for the inheritable blood disorders community. Industry uniQure Announces Published Trial Results for Approved Gene TherapyFeb 27, 2023 Industry FDA Approves ALTUVIIIO™ for Hemophilia A PatientsFeb 24, 2023 Medical WFH Gene Therapy Registry Goes LiveJan 31, 2023 Industry Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM Jan 30, 2023 Industry New FIX Chromogenic Assay Launched by Precision BioLogic Jan 18, 2023 Industry Biomarin Provides Hemophilia A Clinical Development Program UpdatesJan 10, 2023 Industry Takeda Announces Trial Results on Investigational Therapy for…Jan 10, 2023 Industry Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…Jan 4, 2023 Industry Spark Announces SPK-8011 Updates at ASHDec 15, 2022 Medical First Hemophilia B Gene Therapy Approved by FDANov 23, 2022 Medical New Document to Help Residential Substance…Nov 14, 2022 Industry BioMarin Shares Community Update for Valoctocogene RoxaparvovecOct 3, 2022 Industry Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial Sep 23, 2022 Medical Update for the Hemophilia CommunitySep 12, 2022 Medical Virtual Grand Round Series to Focus on Hemophilia Gene TherapySep 12, 2022 Pagination First page Previous page Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page